Equity research analyst Rajiv Kaul will take over management of the Fidelity Select Biotechnology Portfolio and Fidelity Advisor Biotechnology Fund, replacing Harlan Carere.

Kaul previously managed the Fidelity Select Biotechnology Portfolio, the Fidelity Select Developing Communications Portfolio, and most recently the Fidelity Advisor Aggressive Growth Fund, VIP Aggressive Growth Portfolio and the Fidelity Aggressive Growth Fund.

Carere will continue managing the Fidelity Select Health Care Portfolio, Fidelity Advisor Health Care Fund, VIP Health Care Portfolio and Fidelity Select Pharmaceuticals Portfolio.  

Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE